Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Anixa Biosciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ANIX
Nasdaq
8731
https://www.anixa.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Anixa Biosciences Inc
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
- Apr 18th, 2024 12:20 pm
Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
- Mar 14th, 2024 12:45 pm
Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
- Mar 11th, 2024 12:00 pm
We Think Anixa Biosciences (NASDAQ:ANIX) Can Easily Afford To Drive Business Growth
- Feb 17th, 2024 2:03 pm
Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial
- Feb 12th, 2024 12:30 pm
Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference
- Jan 29th, 2024 1:50 pm
Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
- Jan 23rd, 2024 12:55 pm
Sidoti Events, LLC's Virtual January Micro-Cap Conference
- Jan 16th, 2024 1:47 pm
Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024
- Jan 10th, 2024 2:00 pm
Anixa Biosciences to Present at Biotech Showcase 2024
- Dec 14th, 2023 12:15 pm
3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023
- Dec 11th, 2023 5:26 pm
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
- Dec 6th, 2023 11:00 pm
Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
- Dec 6th, 2023 9:05 pm
Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
- Nov 27th, 2023 1:30 pm
Dermata (DRMA) Up on FDA Nod to Begin Pivotal Study of Acne Drug
- Nov 17th, 2023 2:06 pm
Ardelyx (ARDX) Up on Xphozah's Orphan Tag for Hyperphosphatemia
- Nov 17th, 2023 2:00 pm
Kodiak (KOD) Beats Q3 Earnings, Provides Pipeline Updates
- Nov 15th, 2023 1:00 pm
Moleculin (MBRX) Up 7% on Upbeat Updates From Annamycin Studies
- Nov 14th, 2023 3:29 pm
Immunovant (IMVT) Q2 Earnings Top Estimates, Pipeline in Focus
- Nov 10th, 2023 12:19 pm
Catalyst (CPRX) Q3 Earnings Miss, Sales Top, '23 View Up
- Nov 9th, 2023 1:16 pm
Scroll